ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
79 hedge funds and large institutions have $17.6M invested in Acorda Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 27 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
96% less call options, than puts
Call options by funds: $101K | Put options by funds: $2.41M
Holders
79
Holding in Top 10
–
Calls
$101K
Puts
$2.41M
Top Buyers
| 1 | +$429K | |
| 2 | +$333K | |
| 3 | +$208K | |
| 4 |
Jane Street
New York
|
+$191K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$175K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$3.35M | |
| 3 | -$1.42M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.08M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$648K |